Transcription Factor-driven Regulation of ILC1 and ILC3
Overview
Affiliations
Mammalian innate lymphoid cells (ILCs) have functional relevance under both homeostatic and disease settings, such as inflammatory bowel disease (IBD), particularly in the context of maintaining the integrity of mucosal surfaces. Early reports highlighted group 1 and 3 ILC regulatory transcription factors (TFs), T-box expressed in T cells (T-bet; Tbx21) and RAR-related orphan nuclear receptor γt (RORγt; Rorc), as key regulators of ILC biology. Since then, other canonical TFs have been shown to have a role in the development and function of ILC subsets. In this review, we focus on recent insights into the balance between mature ILC1 and ILC3 based on these TFs and how they interact with other key cell-intrinsic molecular pathways. We outline how this TF interplay might be explored to identify novel candidate therapeutic avenues for human diseases.
Thompson D, Wabara Y, Duran S, Reichenbach A, Chen L, Collado K Sci Rep. 2025; 15(1):6844.
PMID: 40000680 PMC: 11861978. DOI: 10.1038/s41598-025-88423-4.
Shen G, Wang Q, Li Z, Xie J, Han X, Wei Z Int J Biol Sci. 2024; 20(12):4799-4818.
PMID: 39309440 PMC: 11414386. DOI: 10.7150/ijbs.96338.
GPX4 restricts ferroptosis of NKp46ILC3s to control intestinal inflammation.
Li X, He J, Gao X, Zheng G, Chen C, Chen Y Cell Death Dis. 2024; 15(9):687.
PMID: 39300068 PMC: 11413021. DOI: 10.1038/s41419-024-07060-3.
Yount K, Darville T Vaccines (Basel). 2024; 12(8).
PMID: 39203989 PMC: 11359697. DOI: 10.3390/vaccines12080863.
OLFM4 modulates intestinal inflammation by promoting IL-22ILC3 in the gut.
Xing Z, Li X, He J, Chen Y, Zhu L, Zhang X Commun Biol. 2024; 7(1):914.
PMID: 39075283 PMC: 11286877. DOI: 10.1038/s42003-024-06601-y.